COUMADIN (WARFARIN SODIUM TABLETS, USP) Trademark
Trademark Overview
On Friday, November 4, 2016, a trademark application was filed for COUMADIN (WARFARIN SODIUM TABLETS, USP) with the United States Patent and Trademark Office. The USPTO has given the COUMADIN (WARFARIN SODIUM TABLETS, USP) trademark a serial number of 87226817. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 29, 2023. This trademark is owned by Bristol-Myers Squibb Pharma Company. The COUMADIN (WARFARIN SODIUM TABLETS, USP) trademark is filed in the Pharmaceutical Products category with the following description:
An anticoagulant pharmaceutical preparation
General Information
Serial Number | 87226817 |
Word Mark | COUMADIN (WARFARIN SODIUM TABLETS, USP) |
Filing Date | Friday, November 4, 2016 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, December 29, 2023 |
Registration Number | 5222641 |
Registration Date | Tuesday, June 13, 2017 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, March 28, 2017 |
Trademark Statements
Description of Mark | The mark consists of the words "COUMADIN (WARFARIN SODIUM TABLETS, USP)" in black font and a design of a splash in the colors purple, pink, blue, beige, white and black on a yellow background. |
Goods and Services | An anticoagulant pharmaceutical preparation |
Indication of Colors claimed | The color(s) purple, pink, blue, beige, white, yellow and black is/are claimed as a feature of the mark. |
Disclaimer with Predetermined Text | "(WARFARIN SODIUM TABLETS, USP)" |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, December 29, 2023 |
Primary Code | 005 |
First Use Anywhere Date | Friday, April 12, 2002 |
First Use In Commerce Date | Friday, April 12, 2002 |
Trademark Owner History
Party Name | Bristol-Myers Squibb Pharma Company |
Party Type | 30 - Original Registrant |
Legal Entity Type | 02 - Partnership |
Address | Princeton, NJ 08540 |
Party Name | Bristol-Myers Squibb Pharma Company |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 02 - Partnership |
Address | Princeton, NJ 08540 |
Party Name | Bristol-Myers Squibb Pharma Company |
Party Type | 10 - Original Applicant |
Legal Entity Type | 02 - Partnership |
Address | Princeton, NJ 08540 |
Trademark Events
Event Date | Event Description |
Friday, December 29, 2023 | CANCELLED SEC. 8 (6-YR) |
Monday, June 13, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Tuesday, June 13, 2017 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, March 28, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, March 28, 2017 | PUBLISHED FOR OPPOSITION |
Wednesday, March 8, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, February 16, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Sunday, February 12, 2017 | ASSIGNED TO EXAMINER |
Wednesday, November 9, 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, November 8, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, November 8, 2016 | NEW APPLICATION ENTERED |